Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Factors Affecting Postmastectomy Locoregional Recurrence in Patients with Early Breast Cancer: Are Intrinsic Subtypes Effective?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Many studies have investigated the association between the molecular subtypes of breast cancer and survival. The aim of this study was to identify the effects of intrinsic subtypes of breast cancer and the other clinicopathological factors on postmastectomy locoregional recurrence (LRR) in patients with early breast cancer.

Methods

The records of 1,195 consecutive early breast cancer patients treated with modified radical mastectomy between 2004 and 2008 were retrospectively evaluated. The effects of intrinsic subtypes of the tumor (luminal A, luminal B, HER2-overexpressing, and triple-negative) and classical clinicopathological factors on LRR were identified by univariate and multivariate statistical analyses.

Results

The median follow-up time was 44 months, and 16 (1.3%) patients experienced a LRR during this period. In univariate analysis, the intrinsic subtypes of breast cancer had a significant effect on LRR (p = 0.002). In multivariate analysis, only extranodal invasion and estrogen receptor (ER) status were significant predictors of LRR (p = 0.003 and 0.0001, respectively), whereas intrinsic subtypes did not reveal a significant relationship with LRR (p = 0.57; hazard ratio, 2.9; 95% confidence interval, 0.2–4.7).

Conclusions

The results of this study suggest that the extranodal invasion and negative ER status should potentially be considered when evaluating the risk of LRR. The predictive power of intrinsic subtypes for LRR is less than that of classical pathological indicators. This information may be useful in planning management of LRR in early breast cancer patients treated with mastectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Buchanan CL, Dorn PL, Fey J et al (2006) Locoregional recurrence after mastectomy. J Am Coll Surg 203:469–474

    Article  PubMed  Google Scholar 

  2. Carreno G, del Casar JM, Corte MD et al (2007) Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Res Treat 102:61–73

    Article  PubMed  Google Scholar 

  3. Jager JJ, Volovics L, Schouten LJ et al (1999) Locoregional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 50:267–275

    Article  PubMed  CAS  Google Scholar 

  4. Livi L, Saieva C, Detti B et al (2007) Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. Eur J Surg Oncol 33:977–981

    PubMed  CAS  Google Scholar 

  5. Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Eng J Med 337:949–955

    Article  CAS  Google Scholar 

  6. Overgaard M, Jensen MB, Overgaard J et al (1999) Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group 82c randomised trial. Lancet 353:1641–1648

    Article  PubMed  CAS  Google Scholar 

  7. Ragaz J, Olivotto IA, Spinelli JJ et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of British Columbia Randomized Trial. J Natl Cancer Inst 97:116–126

    Article  PubMed  Google Scholar 

  8. Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423

    Article  PubMed  CAS  Google Scholar 

  9. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752

    Article  PubMed  CAS  Google Scholar 

  10. Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826

    Article  PubMed  CAS  Google Scholar 

  11. van de Vijver MJ, He YD, van’t Veer LJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009

    Article  PubMed  Google Scholar 

  12. Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:1–13

    Article  Google Scholar 

  13. Bidard FC, Conforti R, Boulet T et al (2007) Does triple-negative phenotype accurately identify basal-like tumour? An immunochemical analysis based on 143 ‘triple-negative’ breast cancers. Ann Oncol 18:1285–1286

    Article  PubMed  Google Scholar 

  14. Bertucci F, Finetti P, Cervera N et al (2008) How basal are triple-negative breast cancers? Int J Cancer 123:236–240

    Article  PubMed  CAS  Google Scholar 

  15. Tan DS, Marchio C, Jones RL et al (2008) Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat 111:27–44

    Article  PubMed  CAS  Google Scholar 

  16. Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367–5374

    Article  PubMed  CAS  Google Scholar 

  17. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874

    Article  PubMed  CAS  Google Scholar 

  18. Carey LA, Dees EC, Sawyer L et al (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13:2329–2334

    Article  PubMed  CAS  Google Scholar 

  19. Bauer KR, Brown M, Cress RD et al (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721–1728

    Article  PubMed  Google Scholar 

  20. Harris LN, Broadwater G, Lin NU et al (2006) Molecular subtypes of breast cancer in relation to paclitaxel response, outcomes in women with metastatic disease: results from CALGB 9342. Breast Cancer Res 8:R66

    Article  PubMed  Google Scholar 

  21. Brown M, Tsodikov A, Bauer KR et al (2008) The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999–2004. Cancer 112:737–747

    Article  PubMed  Google Scholar 

  22. Kurebayashi J, Moriya T, Ishida T et al (2007) The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast 16(Suppl 2):S72–S77

    Article  PubMed  Google Scholar 

  23. Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York

    Google Scholar 

  24. Jatoi I, Porschan MA (2005) Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 28:289–294

    Article  PubMed  Google Scholar 

  25. Chung CS, Harris JR (2007) Postmastectomy radiation therapy: translating local benefits into improved survival. Breast 16:S78–S83

    Article  PubMed  Google Scholar 

  26. Cheng SH, Horng CF, Clarke JH et al (2006) Prognostic index score clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys 64:1401–1409

    Article  PubMed  Google Scholar 

  27. Vlastos G, Rubio IT, Mirza NQ et al (2000) Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol 7:581–587

    PubMed  CAS  Google Scholar 

  28. Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373–2378

    Article  PubMed  Google Scholar 

  29. Haffty BG, Yang Q, Reiss M et al (2006) Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24:5652–5657

    Article  PubMed  Google Scholar 

  30. Voduc KD, Cheang M, Tyldesley S et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684–1691

    Article  PubMed  Google Scholar 

  31. Millar EK, Graham PH, O’Toole SA et al (2009) Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27:4701–4708

    Article  PubMed  Google Scholar 

  32. Dent R, Trudeau M, Pritchard KI et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429–4434

    Article  PubMed  Google Scholar 

  33. Van’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536

    Article  Google Scholar 

  34. Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Caroline Breast Cancer Study. JAMA 295:2492–2502

    Article  PubMed  CAS  Google Scholar 

  35. Rakha EA, El-Rehim DA, Paish C et al (2006) Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer 42:3149–3156

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Ankara Oncology Training and Research Hospital, Ankara, Turkey

    Hakan Mersin, Kaptan Gülben, Uğur Berberoğlu, Mete Yazι, Gökçe Acun, Volkan Kιnaş & Şükrü Erdoğan

  2. Kardelen mah. 2040. Sok. B-blok, no:27, 06370, Ankara, Turkey

    Kaptan Gülben

Authors
  1. Hakan Mersin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaptan Gülben
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uğur Berberoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mete Yazι
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gökçe Acun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Volkan Kιnaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Şükrü Erdoğan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaptan Gülben.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mersin, H., Gülben, K., Berberoğlu, U. et al. Prognostic Factors Affecting Postmastectomy Locoregional Recurrence in Patients with Early Breast Cancer: Are Intrinsic Subtypes Effective?. World J Surg 35, 2196–2202 (2011). https://doi.org/10.1007/s00268-011-1240-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1240-2

Keywords

Search

Navigation